MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Intermediaries
Private Equity, Investment Banking, Financial Services, Factoring
Analysts, Investment Banks: Top Performing Recommendations & Analysis
Oppenheimer & Co. Inc.
Michael Wiederhorn, Oppenheimer_top healthcare analyst in 2018 with a 76% success rate and 9.9% average return. Wiederhorn’s “buy” recommendation of Amedisys (AMED–Research Report), one of the largest hospice-care providers in the US
Amedisys Inc. (AMED)
Organization & Developments: Amedisys
Parents
Amedisys Inc. (AMED)
Children
2018: Amedisys Is A Solid Buy Opportunity In 2018_seekingalpha.com
2022: Amedisys: No Change To Thesis, Retain Hold_ seekingalpha.com
Jumps
*Key People: Amedisys
Finance & Acquisitions: Amedisys